CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Raltegravirdrug
Likely dose
Raltegravir 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00745368
NCT00745368N/ACompleted
CompareCT.gov

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

University of Rochester·interventional·Posted Sep 3, 2008·Updated Oct 10, 2012

In Brief

A clinical study evaluating Raltegravir for HIV Infections. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this research study is to determine how much raltegravir gets into the male and female genital tract.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 3, 2008
Enrollment StartSep 1, 2008
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.8 years ago

Interventions

Raltegravirdrug

400 mg tablets twice daily during duration of trial